RxDoctor Payments Data

Shaila Khowja

Family · Houston, TXNPI 1528451176

Payments from drug & device makers

$25,332in general payments, 2019–2025

Across 92 payments — averaging $275.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$25K
  • Vifor Pharma, Inc.$198
  • AstraZeneca$93
  • Ardelyx, Inc.$29
  • Abbott$25
  • Akebia Therapeutics Inc$21

What the payments were for

  • Speaking & faculty fees$16,79066%
  • Travel & lodging$6,45025%
  • Food & beverage$2,0928%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)84$24,965
Vifor Pharma, Inc.4$198
AstraZeneca1$93
Ardelyx, Inc.1$29
Abbott1$25
Akebia Therapeutics Inc1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,332 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$2,506
Medicare patients
35
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →